Evaluate stage 4 lymphoma treatment centers on multidisciplinary teams, CAR-T access, pricing transparency, same-week appointments, and integrative care. Compare Pi Cancer Care and category benchmarks.

Stage 4 lymphoma patients in India face critical decisions when selecting treatment centers that balance clinical innovation, cost accessibility, and personalized protocol design. Government hospitals, private chains, and coordination platforms each offer distinct approaches to advanced lymphoma care, requiring patients to evaluate facility capabilities against individual priorities. Key Takeaways Personalized stage 4 lymphoma care integrates molecular profiling, subspecializ

TL;DR Pi Cancer Care by Dr.Bharat Patodiya offers comprehensive CAR-T cell therapy evaluation and connects lymphoma patients with leading treatment centers across India, with costs ranging from ₹30-50 lakhs compared to ₹3-4 crores internationally [1] India now has 2 FDA-approved CAR-T therapies (NexCAR19 and Qartemi) achieving 70-83% response rates in clinical trials, making treatment 80% more affordable than abroad [1] Leading centers include Tata Memorial Hospital, HCG Canc